Stryker has had a rough stretch on the market over the past year, and the gap between its share price and its underlying cash generation has become a key issue for investors. With the stock back at US$282.55 and the business making fresh moves in surgical robotics, the question is how well that tag lines up with the company’s future cash flows.
- The share price has fallen 22.8% over the past year, which puts the focus squarely on whether that decline now matches the long term cash stream the business can produce.
- The US$400m investment in CMR Surgical and exclusive U.S. rights to the Versius system can reshape expectations for Stryker’s capital needs and the timing of any new cash inflows from robotic surgery.
- What if you looked at Stryker through its earnings instead? See what Stryker's 29.1x P/E says about the price.
The issue now is whether today’s US$282.55 share price is supported by Stryker’s projected cash flows when stacked against an intrinsic value estimate built from a Discounted Cash Flow (DCF) model.
If you want a wider starting point while you assess Stryker and its cash flows, consider running the same lens across 32 high quality undervalued stocks.
Does Stryker Look Undervalued on Cash Flow?
The Discounted Cash Flow (DCF) approach values Stryker by projecting the cash it can return to shareholders and then discounting those streams back to today. Over the last twelve months the group produced about $4.7b of free cash flow, and the 2 Stage Free Cash Flow to Equity model then assumes this pool of cash continues to grow rather than contract over the coming decade. That steady build in projected free cash flows supports an intrinsic value estimate that sits meaningfully above the current US$282.55 share price.
Stryker’s recent $400m commitment to CMR Surgical and the Versius platform helps explain why the model builds in ongoing cash generation, since the partnership points to continued investment in areas that already link back to its medical technology base. Despite near term share price pressure around the CEO transition planned for 2027, the DCF still indicates the market is pricing Stryker below what its current and projected cash flows support. Find out what Stryker could be worth using our Discounted Cash Flow (DCF) estimate.
The Stryker Narrative: What Would Justify Today's Price?
Simply Wall St Narratives for Stryker pick up where the cash flow puzzle leaves off and explain what kind of growth, margins, and earnings profile would need to hold for the stock to be worth materially more or less than today’s price. These Narratives are available on the company’s Community page. Each scenario connects Stryker’s potential catalysts and key risks to a specific fair value so you can monitor over time which version of events is actually unfolding.
One of the top community narratives on Stryker: 23% undervalued
"Stryker needs continued strong uptake of Mako systems and Smart Care offerings, together with effective execution on manufacturing and supply chain changes..."
Discover why this Narrative puts Stryker at 23% undervalued.
Stryker’s valuation still leaves one crucial piece off the table
The cash flow story tells you what Stryker is worth, but the people choosing where every dollar goes, how they are rewarded, and what they are aiming for can change that picture entirely. See who runs Stryker and how they are paid.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com